Parathyroid Disorders and Metabolic Bone Disease (posters) (posters)

FRI 324

Unrecognized High Prevalence of and Risk Factors for Low Bone Mineral Density in Patients with an Inherited Channelopathy
Gyung Min Lee, Yang-Hee Park, Sung-Jae Lee, Chae-Hyuk Choi, Jeong-Hoon Seo and June-Bum Kim

FRI 327

Hypoparathyroidism - Descriptive Results of a Large Retrospective Austrian Cohort
Verena Schwetz, Martin Kern, Andrea Bradatsch, Christian Trummer, Gerhard Wolf, Thomas R Pieber, Jutta Claudia Piswanger-Soelkner, Harald Dobnig and Karin Amrein

FRI 329

Prognostic Factors of Overall Recurrence and Survival in Parathyroid Carcinoma; The Largest Single Institution Experience over the Last 3 Decades in USA
Angelica Maria Silva, Lily J Kwatampora, Ioannis Christakis, Carla Warneke, Michelle D Williams, Callisia Clarke, Elizabeth G Grubbs, Jeffrey E Lee, Nancy D Perrier and Naifa L Busaidy

FRI 330

Sarcoidosis Presenting with Acute Renal Failure, Hypercalcemia and Hyperkalemia
Regina Belokovskaya, Francisco Perez Mata and Oksana Davydov

FRI 331

Physical Activity and the Risk of Developing Primary Hyperparathyroidism
Anand Vaidya, Gary Curhan, Julie Paik, Molin Wang and Eric Taylor

FRI 332

Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation
Namita G. Hattangady, Tremika Le-Shan Wilson, Barbra S. Miller, Antonio M Lerario, Thomas J Giordano, Palak Choksi and Tobias Else

FRI 333

Occult Nephrolithiasis in Primary Hyperparathyroidism
Leonardo Bandeira, Diane Cozadd, Mariana Bucovsky, Donald J McMahon, James A Lee, Shonni J. Silverberg and Marcella D. Walker

FRI 335

Bone Mineral Density in Primary Hyperparathyroidism: The Effects of PTH, 25-Vitamin D and 1,25-Vitamin D
Thomas Ian Hadwen, Melissa Clarke, Luke Conway, Anna-Gerardina Mclean and Ashim Kumar Sinha

FRI 338

Unsuspected Parathyroid Cancer: A Case Report
Yousuf Khan and David S Schade

FRI 340

Effects of Vitamin D Supplementation in Primary Hyperparathyroidism
Betiana Mabel Perez, Maria Pia Podesta, Rodrigo Serrano Salinas, Giovana Rosario Córdoba Figueroa, Magdalena Pavlove, Silvia Viviana Karlsbrum and Helena H Salerni

FRI 341

Hyperparathyrodisim in Men - Low Morbidity and Mortality during 20 Years´Follow-up
Georgios Kontogeorgos, Christine Laine, Lennart X Welin, Michael Fu, Per-Olof Hansson and Kerstin Landin-Wilhelmsen

FRI 342

Extensive Clinical Experience in the Investigation and Management of Primary Hyperparathyroidism
Laura J Reid, Balakumar Muthukrishnan, Andrew Ditchfield, Andrew Brodie and Fraser W Gibb

FRI 343

Bone Mineral Density Screening Importance in Men with Sporadic Primary Hyperparathyroidism
Danica Maria Vodopivec, Angelica Maria Silva, Kelly Schwarz, Ioannis Christakis, Ashley Stewart, Mimi I-Nan Hu and Nancy D Perrier

FRI 345

Does Subclinical Inflammation Compromise Bone Quality in Women with Polycystic Ovary Syndrome?
Shirin Kalyan, Millan Patel, Elaine Kingwell, Helene Cote, Danmei Lui and Jerilynn C Prior

FRI 347

FGF-23 As a Novel Predictor of Hospital Mortality in Critically Ill Patients
Karin Amrein, Verena Schwetz, Nicolas Verheyen, Astrid Fahrleitner-Pammer, Christian Schnedl, Thomas R Pieber and Harald Dobnig

FRI 348

Chronic High Dose Proton-Pump Inhibitors As a Cause of Hypophosphatemic Rickets
Margaret Wolfe-Wylie, Marialena Mouzaki, Etienne B Sochett and Jennifer Jean Harrington